EGFR and prostate carcinoma: In other studies on prostate cancer cells cyclopamine used in combination with ErbB inhibitors gefitinib or lapatinib showed a synergistic effect [41], [42] and combination of docetaxel+cyclopamine+gefitinib induced more intensive cell death compared to either treatment alone [43].